EyeWorld India September 2019 Issue

EWAP SEPTEMBER 2019 3 EDITORIAL T he focus of the September issue of EyeWorld Asia-Pacific is a comprehensive discussion of technological innovations that advance outcomes in cataract and refractive surgery. The topics range from methods of cataract surgery and intraocular aberrometry to MIGS and the delivery of therapeutic agents. If we reflect on the advances of recent decades, there is no doubt that technological improvements stand out as one of the most important ways we have been able to improve outcomes after cataract and refractive surgery. Nevertheless, in recent years it appears the benefits are more incremental rather than the exponential gains that were evident in past decades. There is still a debate whether femtosecond cataract surgery offers real benefits in outcomes and whether intraocular aberrometry does provide better outcomes than careful planning and utilization of advanced formulae. Similarly, MIGS devices have an excellent safety profile but are as yet not as effective as well-established drainage procedures such as trabeculectomy and tube surgery. Heads-up displays as opposed to traditional surgical microscope is tantalizing but in complex cases direct viewing through the microscope oculars is often preferred as discussed by surgeons experienced with this new technology. Personally, I don’t think one should be disheartened, as often the true impact of new technology may only become evident after some time. I’m certain many of the technological innovations discussed will become firmly established, although their value may only become apparent when we look back in years to come. As important as the new technology is ensuring that training and the acquisition of new skills keeps pace with the new technologies so that these can be used to the best advantage of our patients and improve outcomes. It’s certainly an exciting time to be practicing ophthalmology when there are so many new technologies being considered as evident in this issue of our news journal. I look forward to an exciting annual meeting in Kyoto this year which will provide a wonderful opportunity to discuss and explore the many technologies presented here in our September issue. Level Up Graham Barrett Chief Medical Editor EyeWorld Asia-Pacific T he new issue of scientifically enriched EyeWorld Asia-Pacific is out for the month of September with features on new and innovative techniques. 3D cataract surgery is a promising new technology that can pave the path to an ergonomically better OR for all of us surgeons. Following this is an article on the ongoing innovations in the ever-evolving field of cataract surgery. Next up, newer approaches to diagnosis and treatment in glaucoma patients. Newer and better drug delivery formulations and devices being the need of the hour make a well-deserved mention in our journal this time. Electronic health records are here to stay—our article discusses the pros and cons of having an EHR in your clinic. The article on the XEN 45 ab externo, a much talked about implant, has experts discussing the various practices, techniques, and variations of implants available. Our next article aims at deepening our understanding of the COMPARE study. We end the glaucoma section by discussing the complications of MIGS surgery. Our cataract section begins with the discussion of use of Omidria in FLACS cases. Next, we discuss the relation between progress of AMD and cataract surgery. In our refractive section, we talk about the controversial use of inlay in pseudophakic patients. Our next article goes on to discuss the possible need to look for more accurate IOL calculation formulae than the ones in current use. An article based on a lipoic acid choline ester, which could prove to be the eureka moment in the field of refractive errors, details the effect of this new drug under trial. Keeping up with the pace of the cornea world, our section on cornea deals with newer techniques in corneal transplants, anti-inflammatory substances for ocular surface management and IOL power calculations incorporating intraoperative aberrometry. We end this edition with detailed articles on pupil dilating devices, the Light-adjustable Lens, and use of intracameral antibiotics in cataract surgery. As always I would like to conclude with a quote from Tirukkural : One who, in his envy, doesn’t appreciate the wealth of others, is known not to value virtue and his own wealth. ( Tirukkural , Chapter 17, Quote 163) S. Natarajan, MD Regional Managing Director EyeWorld Asia-Pacific EWAP SE T he focus of the September ssue of EyeWorld Asia-Pacific is a comprehensive discussion of technological innovations th t adva ce outcomes in cataract and refractive surgery. Th topics range f om methods of cataract surgery and intraocular aberrometry to MIGS and the delivery of therapeutic agents. If we reflect on the adva ces of recen decades, there is no doubt that tech ol gic l improvements stand out as one of the most important ways w have be n able to improve outcomes after cataract and r fractiv surgery. Nevertheless, in recent years it appea s th benefits are mor increm l rather than the exponential gains th t were evident in past decades. Ther is still a deb e whether femtosecond catara t surgery offers real b nefits in outcomes and whether intraocular aberrometry does provid better outcomes han careful plan ing and utilization of advanced formulae. Similarly, MIGS d vices have an excellent safety profile but are as yet not as effective as well-established drainage procedures such as t abecul ctomy and tube surgery. Heads-up displays as oppos d to trad tional surgical m crosco is t ntalizing but in complex cases direct viewing through the microscope ocular is often preferred as discussed by surgeons xperienced with this new technology. Personally, I n’t thi k one should b disheartened, as often the true impact of new t chnology may nly become evident after some time. I’m certain many of the te hnological inn vations discussed will become firmly established, although their v lue may only become apparent when we look back in years to come. As important as the new technology is ensuring that trai ing and th acquisition of n w skills keeps pace with the n w technologies so that these c be used to the best advantage of our patients and improve outcomes. It’s certainly an exciting ti e t be practicing ophthalmology when there are so many ew t chnologi s being considered as evident in this issue f our news journal. I look forward to a exciting annual meeting in Kyoto this year which will provide a wonderful opportunity to discuss and explo the many technologies pres nted here in our September issue. Level Up Graham Barrett Chief Medical Editor EyeWorld Asia-Pacific T he new issue of scientifically enriched EyeWorld Asia-Pacific is out for the month of September with features on new and innovative techniques. 3D cataract surgery is a promising new technology that can pave the path to an ergonomically better OR for all of us surgeons. Following this is an article on the ongoing innovations in the ever-evolving field of cataract surgery. Next up, newer approaches to diagnosis in glaucoma patients. N wer and better dru formulations and d vices being the need of make a well-deserved mention in our journa Electronic health records are here to stay—o discusses the pros a d cons of having an EH clinic. Th article on the XEN 45 ab externo, talked abo t implant, has experts discussing p ac ce , technique , and variations of impl Our ext a ticle aims at deepening our unde the COMPARE study. We end the glaucoma discussing the complications of MIGS surger Our cataract secti begins with the disc of Omidria n FLACS cases. Next, we discus between progress of AMD and cataract surg In our refractive section, we talk about the use of inlay in pseudophakic patients. Our ne on to discuss the possible n ed to look for m IOL calculation formula tha the ones in cur article based on a lipoic acid choline ester, w prove to be the eu k moment in the field o errors, details the effect of this new drug und Keeping up with the pace of the cornea section on ornea deals with newer techniq corne l t ansplants, anti-inflammatory subst ocular surface manageme t and IOL power incorp rating intraoperative aberrometry. We end his edition with detailed articles ilating devices, the Light-adjustable Lens, intr ame al antibiotics in cataract surgery. As always I would like to conclude with a Tirukkural : One who, in his nvy, doesn’t appreciate others, is known not to value virtue and his ( Tirukkural , Chapter 17, Quote 163) S. Nata Regional Ma EyeWorld